Data Bridge Market Research analyses that the dysphagia market was valued at USD 3.05 billion in 2021 and is expected to reach USD 4.62 billion by 2029, registering a CAGR of 5.30% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework

In recent years, the dysphagia market is anticipated to proliferate during the forecast period. According to the World Heart Association, the global incidence rate of stroke is 15 million, with 6 million people dying and another 6 million becoming disabled, resulting in vision loss and speech impairment. As a result, the rising prevalence of stroke-related dysphagia and associated pharyngeal and laryngeal problems is propelling the dysphagia market forward. Cerebrovascular accidents (strokes) are caused by insufficient blood supply (oxygen and nutrients) to the brain.

Dysphagia is a condition in which people have trouble swallowing food. The ability to swallow safely is critical for proper nutrition and hydration as well as preventing food from entering the lungs. Swallowing is a complicated act that requires coordinated muscular activity in three basic phases: oral phase (mouth), pharyngeal phase (throat), and esophageal phase (food tube). Dysphagia is a condition that occurs when one or more of these stages are disrupted. Food texture modifying products and other products such as tubes are used to aid in the swallowing process in dysphagia management.

this business report introduces the basics of industry such as market definitions, classifications, applications and industry chain overview, after which it covers industry policies and plans, product specifications, manufacturing processes, cost structures and so on.

View Detailed Report@  https://www.databridgemarketresearch.com/reports/global-dysphagia-market

Drivers

Rising number of people addicted to smoking

The rising number of people addicted to smoking is anticipated to influence the dysphagia market's growth during the forecast period. One of the most serious adverse effects of smoking cigarettes for an extended period of time is dysphagia. While tobacco use kills approximately 6 million people each year, the rising prevalence of oropharyngeal cancer is progressively fueling the expansion of the dysphagia market.

Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of dysphagia market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the dysphagia market. Additionally, high disposable income and surging demand for dysphagia management in healthcare services and medical facilities will expand the dysphagia market. Along with this, rising geriatric population and continuously changing lifestyle will enhance the market's growth rate.

Competitive Landscape and Dysphagia Market Share Analysis

The dysphagia market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to dysphagia market.

Some of the major players operating in the dysphagia market are:

• Reddy's Laboratories Ltd. (India)
• AstraZeneca (UK)
• Johnson & Johnson Private Limited (US)
• Abbott (US)
• Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (US)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Novartis AG (Switzerland)
• Sun Pharmaceutical Industries Ltd. (India)
• Aurobindo Pharma (India)
• Pfizer Inc. (US)
• GlaxoSmithKline plc (UK)
• Reddy's Laboratories Ltd. (India)
• Cipla Inc. (US)
• Zydus Cadila (India)
• WOCKHARDT (India)
• Lannett (US)
• Cook (US)
• Fresenius Kabi AG (Germany)
• BD (US), Eisai Co., Ltd. (Japan)

This Market Intelligence Report Analyses Some of the Most Crucial Concerns:

• How will the major segments of this international market develop over the next few years?
• Who are the major players that will dominate the market in the future?
• When it comes to this industry, who are the top suppliers and producers?
• How have the most successful companies in the industry planned for future growth and expansion?
• In what sectors might we expect to see the greatest increase in demand over the coming years?
• How many distinct subsets of buyers make up this market?
• Which regional powerhouse do you foresee as becoming the largest player in the international market?
• Does a new coronavirus pandemic have any consequences?
• In what ways are established actors stymied by the entry of newcomers, and how may they be overcome?

Investing in this study would grant you access to valuable information, including:

• Regional-level breakdowns of the market, including North America, Europe, Asia Pacific, South America, and the Middle East & Africa.
• Country-specific market size splits for the most important countries with major market shares.
• Market share and revenue/sales data for the industry's leading players.
• Analysis of market trends such as emerging technologies, products, and start-ups, as well as PESTEL Analysis, SWOT Analysis, Porter's Five Forces, and more.
• Detailed market size data, including breakdowns by application/industry verticals.
• Projections and forecasts for the market's future growth and development.

More Links:

https://www.databridgemarketresearch.com/reports/global-congestive-renal-failure-crf-market

https://www.databridgemarketresearch.com/reports/global-uterotonic-agent-market

https://www.databridgemarketresearch.com/reports/global-hematuria-treatment-market

https://www.databridgemarketresearch.com/reports/global-antidotes-market

https://www.databridgemarketresearch.com/reports/global-cephalosporins-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decisionmaking process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: corporatesales@databridgemarketresearch.com